Skip to main content
. 2023 Feb 14;24(4):3807. doi: 10.3390/ijms24043807

Figure 8.

Figure 8

Representative image and quantitative analysis of ROS generation measured by DCF-DA assay according to VEGFR1 or VEGFR3 inhibition in HG-treated human GECs with or without febuxostat. *** p < 0.001.